Combined high expression of CD47 and CD68 is a novel prognostic factor for breast cancer patients.
Jingping YuanHuihua HeChuang ChenJuan WuJie RaoHong-Lin YanPublished in: Cancer cell international (2019)
Combined detection of CD47 and CD68 may provide guidance for the prognosis of breast cancer, especially hormone receptor-negative breast cancer.
Keyphrases